Administration of the muscarinic agonist bethanechol increased insulin secretion and improved glucose tolerance in insulin-receptor substrate 2 (IRS2)-knockout (IRS-2−/−) mice and diet-induced obesity mice. This evidence concerns the gene IRS2 and obesity due to melanocortin 4 receptor deficiency.